» Articles » PMID: 36635623

Evaluation of Two Laboratory Model Methods for Diarrheal Irritable Bowel Syndrome

Overview
Journal Mol Med
Publisher Biomed Central
Date 2023 Jan 12
PMID 36635623
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Diarrheal irritable bowel syndrome (IBS-D) is a common chronic functional gastrointestinal disorder, and the underlying pathogenic mechanism is still unclear. Animal models that mimic the pathological state of IBS-D patients were constructed to provide a reference for later drug research and model development.

Methods: The IBS-D model was induced using restraint stress and chemical stimulation (rhubarb), and rats were divided into normal control group (NC), chemically stimulated group (CS), and restraint stress group (RS). Visceral motility responses to Colorectal Balloon Dilation (CRD) were measured by Abdominal Withdrawal Reflex (AWR); evaluation of faecal properties and water content; determination of colonic tissue tight junction (TJ) mRNA expression by RT-PCR; measurement of inflammatory cytokines by ELISA; and intestinal flora and short chain fatty acids.

Results: Compared to NC group, CS and RS group rats showed increased intestinal sensitivity and Bristol stool score, significant diarrheal symptoms and weight loss. Mucin 2, ZO-1, OCLN, CLDN4 mRNA expression was reduced and the intestinal mucosal barrier function was diminished. In addition, the levels of inflammatory factors IL-1β, IL-6, IL-8, IL-10 and TNF-α increased, the abundance and diversity of intestinal flora decreased, the content of beneficial bacteria such as Bifidobacteria decreased, and SCFAs such as acetic acid, propionic acid and butyric acid decreased to different degrees. Although, no significant difference was observed for any molecular and inflammatory marker, but compared to CS group, RS group had less water in the stool, higher visceral sensitivity, and higher relative abundance of beneficial intestinal bacteria such as Actinobacteria.

Conclusion: In conclusion, restraint stress combined with chemical stimulation can mimic the pathological state of diarrhoea symptoms, visceral hypersensitivity, reduced intestinal mucosal barrier permeability, immune regulatory dysfunction and dysbiosis in IBS-D patients. However, herbs with antibacterial effects such as rhubarb and senna, for example, are not suitable as the first choice for chemical stimulation, as they may lead to a decrease in harmful bacteria and an increase in beneficial bacteria in the intestinal fraction and do not perfectly mimic the imbalanced state of intestinal flora in IBS-D patients, while restraint stress may be a key factor in modelling.

Citing Articles

Serum salusin levels in diarrhea- and constipation-predominant irritable bowel syndrome.

Tuncel E, Ozcan S, Korkmaz M, Borekci E PeerJ. 2025; 13:e18859.

PMID: 39897500 PMC: 11787801. DOI: 10.7717/peerj.18859.


6-Shogaol Derived from Ginger Inhibits Intestinal Crypt Stem Cell Differentiation and Contributes to Irritable Bowel Syndrome Risk.

Zhao B, Ye J, Zhao W, Liu X, Lan H, Sun J Research (Wash D C). 2024; 7:0524.

PMID: 39512446 PMC: 11542252. DOI: 10.34133/research.0524.


Inflammatory Prostatitis Plus IBS-D Subtype and Correlation with Immunomodulating Agent Imbalance in Seminal Plasma: Novel Combined Treatment.

Castiglione R, Bertino G, Vicari B, Rizzotto A, Sidoti G, DAgati P Diseases. 2024; 12(10).

PMID: 39452503 PMC: 11508116. DOI: 10.3390/diseases12100260.


Sinisan Alleviates Stress-Induced Intestinal Dysfunction and Depressive-like Behaviors in Mice with Irritable Bowel Syndrome by Enhancing the Intestinal Barrier and Modulating Central 5-Hydroxytryptamine.

Zeng H, Jiang Y, Yin Q, Li X, Xiong Y, Li B Int J Mol Sci. 2024; 25(19).

PMID: 39408592 PMC: 11476996. DOI: 10.3390/ijms251910262.


Tongxieyaofang Decotion Alleviates IBS by Modulating CHRM3 and Gut Barrier.

Feng T, Zhou Y, Lv B, Cai L Drug Des Devel Ther. 2024; 18:3191-3208.

PMID: 39081703 PMC: 11288639. DOI: 10.2147/DDDT.S455497.


References
1.
Mitselou A, Grammeniatis V, Varouktsi A, Papadatos S, Katsanos K, Galani V . Proinflammatory cytokines in irritable bowel syndrome: a comparison with inflammatory bowel disease. Intest Res. 2020; 18(1):115-120. PMC: 7000645. DOI: 10.5217/ir.2019.00125. View

2.
Ancona A, Petito C, Iavarone I, Petito V, Galasso L, Leonetti A . The gut-brain axis in irritable bowel syndrome and inflammatory bowel disease. Dig Liver Dis. 2020; 53(3):298-305. DOI: 10.1016/j.dld.2020.11.026. View

3.
Crouzet L, Gaultier E, Delhomme C, Cartier C, Delmas E, Dapoigny M . The hypersensitivity to colonic distension of IBS patients can be transferred to rats through their fecal microbiota. Neurogastroenterol Motil. 2013; 25(4):e272-82. DOI: 10.1111/nmo.12103. View

4.
Scuderi S, Casili G, Lanza M, Filippone A, Paterniti I, Esposito E . Modulation of NLRP3 Inflammasome Attenuated Inflammatory Response Associated to Diarrhea-Predominant Irritable Bowel Syndrome. Biomedicines. 2020; 8(11). PMC: 7699594. DOI: 10.3390/biomedicines8110519. View

5.
Shamsipour S, Sharifi G, Taghian F . An 8-Week Administration of Bifidobacterium bifidum and Lactobacillus plantarum Combined with Exercise Training Alleviates Neurotoxicity of Aβ and Spatial Learning via Acetylcholine in Alzheimer Rat Model. J Mol Neurosci. 2021; 71(7):1495-1505. DOI: 10.1007/s12031-021-01812-y. View